|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Short-term clinical outcome after acute symptomatic pulmonary embolism显示文摘 | Conget F Otero R Jiménez D | 2008 | Thromb Haemost2008，100，5： | 1 |
| 2 | Serum levels of the interfer-on-gamma-inducing cytokine interleukin-18are increased in individ-uals at high risk of developing type I diabetes显示文摘 | Nicoletti F Conget I Di Marco R | 2001 | Diabetologia2001，44，3： | 1 |
| 3 | Guidelines for the diagnosis, treatment, and follow-up of pulmonary embolism 显示文摘 | Uresandi F Blanquer J Conget F | 2004 | Arch Bronconeumol2004，40，12： | 1 |
| 4 | Short-ter~n clinical outcome after acute symptomatic pulmonary embolism 显示文摘 | Conget F Otero R Jim~nez D | 2008 | Thrombosis and Haemostasis2008，100，： | 1 |
| 5 | Guidelines for the diagnosis,treatment,and follow-up of pulmonary embolism显示文摘 | Blanquer J Conget F | 2004 | Arch Bronconeumol2004，40，： | 1 |
| 6 | Serum concentra- tions of the interferon-alpha inducible chemokine IP-10/CX- CLI0 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease 显示文摘 | Nicoletti F Conget L Di Mauro M | 2002 | Diabetologia2002，45，： | 1 |
| 7 | Serum levels of the in terferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type 1 diabetes显示文摘 | Nicoletti F Conget I Di Marco R | 2001 | Diabetologia2001，44，： | 1 |
| 8 | Improving metabolic control in sub-optimally controlled subjects with Type 1 diabetes: comparison of two treatment algorithms usinginsulin glargine 显示文摘 | Gomis R Storms F Conget I | 2007 | Diabetes Res Clin Pract2007，77，1： | 1 |
| 9 | Guidelines for thediagnosis,treatment,and follow-up of pulmonary embolism显示文摘 | Uresandi F Blanquer J Conget F | 2004 | Arch Bronconeumol2004，40，12： | 1 |
| 10 | Short-term clinical out-- come after acute symptomatic pulmonary embolism 显示文摘 | Conget F Otero R Jimenez D | 2008 | Thromb Haemost2008，100，5： | 1 |
| 11 | Serum levels of interferon-gamma-inducing cytokine interleukin -18 are increased in individuals at high risk of developing type 1 diabetes 显示文摘 | Nicoletti F Conget I DiMarco R | 2001 | Diabetologia2001，44，3： | 1 |
| 12 | Guidelines for the diagno- sis, treatment, and follow-up of pulmonary embolism 显示文摘 | Uresandi F Blanquer J Conget F | 2004 | Arch Bran- coneumol2004，40，： | 1 |
| 13 | Guidelines for the diagnosis, treatment, and follow-up of pulmonary embolism 显示文摘 | Uresandi F Blanquer J Conget F | 2004 | Arch Bronconeumol2004，40，12： | 1 |
| 14 | Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice显示文摘 | Ezquer F E Ezquer M E Parrau D B Carpio D Yanez A J Conget P A | 2008 | Biol Blood Marrow Transplant2008，14，： | 1 |
| 15 | Short-term clinical outcome after acute symptomatic pulmonary embolism显示文摘 | Conget F Otero R Jimenez D | 2008 | Thromb Haemost2008，100，5： | 1 |
| 16 | Guidelines for the diagnosis,treatment,and follow-up of pulmonary embolism显示文摘 | Blanquer J Conget F | 2004 | Arch Bronconeumol2004，40，： | 1 |
| 17 | Short-term clinical outcome after acute symptomatic pulmonary embolism显示文摘 | Conget F Otero R Jimenez D | 2008 | Thromb Haemost2008，100，5： | 1 |
| 18 | Serum concentrations of the interferon - gamma - inducible chemokine IP - 10/CXCL10 are augmented in both newly diagnosed Tvpe I diabetes mellitus patients and subjects at risk of developing the disease显示文摘 | Nicoletti F Conget I Di Mauro M | 2002 | Diabetologia2002，45，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员